menu
    • menu

    Strides Pharma Science's list of EU CTD Dossiers, Marketing Authorizations, In, Out Licensing Opportunities & Finished Dosage Formulations (FDF) aggregated by PharmaCompass

    Strides Pharma Science-PSE
    News
    OneSource in talks to raise Rs 1,670 crore in pre-listing round

    26 Sep 2024

    // ECONOMICTIMES

    Strides Pharma subsidiary receives USFDA approval for 60 mg Fluoxetine tablets

    18 Sep 2024

    // EXPRESSPHARMA

    Strides secures shareholders' nod for OneSource specialty CDMO unit

    11 Sep 2024

    // ECONOMICTIMES

    DATA COMPILATION
    #PharmaFlow

    Strides Pharma Science

    Contact Supplier

    Website

    CPhI Worldwide, Milan

    Booth #5C33

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

    Related CompaniesRelated Companies

    About

    Headquartered in India, Strides Pharma Science Limited is a pharmaceutical company with a major focus on the development and manufacture of IP-led niche finished dosage formulations. It is also among the world's largest manufacturers of soft gelatin capsules. With world-class manufacturing facilities, an innovative R&D hub in Bangalore and a robust commercial platform to market products globally, Strides has earned a reputation for building and scaling profitable businesses in a short span of time.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Strides Pharma Scienceindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Strides House, Bilekahalli, Bannerghatta Road, Bangalore – 560076
    Telephone
    Telephone
    +91 8067840000
    Client Email
    Email
    enquiries@synergice.co
    Client Website
    Website
    https://www.synergice.co/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/synergice/
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    A PHP Error was encountered

    Severity: Warning

    Message: Undefined variable $tile1

    Filename: tabs/exhibitions.php

    Line Number: 43

    Backtrace:

    File: /var/www/html/application/views/include/party/inc/tabs/exhibitions.php
    Line: 43
    Function: _error_handler

    File: /var/www/html/application/models/CmnPec.php
    Line: 1626
    Function: view

    File: /var/www/html/application/views/include/party/query.php
    Line: 575
    Function: create

    File: /var/www/html/application/views/include/party/indexNew.php
    Line: 86
    Function: include

    File: /var/www/html/application/views/commonNew.php
    Line: 1368
    Function: include

    File: /var/www/html/application/controllers/PharmaServices.php
    Line: 4587
    Function: view

    File: /var/www/html/index.php
    Line: 224
    Function: require_once

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    cphi-worldwide-milan-70313.png

    CPhI Worldwide, Milan

    Booth #5C33

    envelop Contact Supplier

    CPhI Worldwide, Milan

    Contact Supplier

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/strides-pharma-science-party-content-34447.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/strides-pharma-science-party-content-3803.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Manufacturing Sites and R&D Center

    read-more

      https://www.pharmacompass.com/pdf/party/content/strides-pharma-science-party-content-28236.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2021

    read-more

      https://www.pharmacompass.com/pdf/party/content/strides-pharma-science-party-content-60913.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    OneSource in talks to raise Rs 1,670 crore in pre-listing round
    OneSource in talks to raise Rs 1,670 crore in pre-listing round

    26 Sep 2024

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/onesource-in-talks-to-raise-rs-1670-crore-in-pre-listing-round/articleshow/113677721.cms

    ECONOMICTIMES
    26 Sep 2024
    Share Share
    Strides Pharma subsidiary receives USFDA approval for 60 mg Fluoxetine tablets
    Strides Pharma subsidiary receives USFDA approval for 60 mg Fluoxetine tablets

    18 Sep 2024

    // EXPRESSPHARMA

    https://www.expresspharma.in/strides-pharma-subsidiary-receives-usfda-approval-for-60-mg-fluoxetine-tablets/

    EXPRESSPHARMA
    18 Sep 2024
    Share Share
    Strides secures shareholders' nod for OneSource specialty CDMO unit
    Strides secures shareholders' nod for OneSource specialty CDMO unit

    11 Sep 2024

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-secures-shareholders-nod-for-onesource-specialty-cdmo-unit/articleshow/113257912.cms

    ECONOMICTIMES
    11 Sep 2024
    Share Share
    Proxy advisors vote against Strides Pharma’s consolidation scheme
    Proxy advisors vote against Strides Pharma’s consolidation scheme

    09 Sep 2024

    // ECONOMICTIMES

    https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/proxy-advisors-vote-against-strides-pharmas-consolidation-scheme/113185732?utm_source=top_news&utm_medium=sectionListing

    ECONOMICTIMES
    09 Sep 2024
    Share Share
    Strides gets USFDA nod for Theophylline extended-release tablets
    Strides gets USFDA nod for Theophylline extended-release tablets

    07 Sep 2024

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-gets-usfda-nod-for-theophylline-extended-release-tablets/articleshow/113115295.cms

    ECONOMICTIMES
    07 Sep 2024
    Share Share
    Strides Pharma`s Generics Theophylline Receives Approval in US
    Strides Pharma`s Generics Theophylline Receives Approval in US

    05 Sep 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215312

    FDA
    05 Sep 2024
    Share Share

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search